Novavax NVAX
NASDAQ NVAX
$10.46 -0.14 (-1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Novavax (NVAX) Cash & Current Investments (2010 - 2026)

Updated

Novavax (NVAX) reported Cash & Current Investments of $719.4 million for Q2 2026, up 17.5% from $612.34 million a year earlier but down 9.0% from the prior quarter.

Analysis

Novavax (NVAX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Novavax posted Cash & Current Investments of $735.08 million, down 20.4% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $923.12 million in FY2024 (+62.4%), $568.51 million in FY2023 (-57.5%), $1.34 billion in FY2022 (-11.8%) and $1.52 billion in FY2021 (+113.1%).
  • Five-year quarterly Cash & Current Investments spans a low of $480.6 million in Q1 2024 and a high of $1.94 billion in Q3 2021.
  • Year over year, Cash & Current Investments gained in five of the last eight quarters, with growth averaging 12.7%.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 284.3%); the low point was Q2 2023 (a decline of 63.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $790.4 million (Q1 2026), $735.08 million (Q4 2025) and $762.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Novavax 1.72 Bn -1.28 Bn 42.45 Mn 719.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 719.40 Mn
Mar 31, 2026 790.40 Mn
Dec 31, 2025 735.08 Mn
Sep 30, 2025 762.92 Mn
Jun 30, 2025 612.34 Mn
Mar 31, 2025 731.48 Mn
Dec 31, 2024 923.12 Mn
Sep 30, 2024 909.53 Mn
Jun 30, 2024 1.05 Bn
Mar 31, 2024 480.60 Mn
Dec 31, 2023 568.51 Mn
Sep 30, 2023 651.10 Mn
Jun 30, 2023 505.91 Mn
Mar 31, 2023 624.95 Mn
Dec 31, 2022 1.34 Bn
Sep 30, 2022 1.28 Bn
Jun 30, 2022 1.38 Bn
Mar 31, 2022 1.57 Bn
Dec 31, 2021 1.52 Bn
Sep 30, 2021 1.94 Bn
API Access

Novavax Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NVAX&period=max&api_key=YOUR_API_KEY